Exact Mass: 847.2719016

Exact Mass Matches: 847.2719016

Found 8 metabolites which its exact mass value is equals to given mass value 847.2719016, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

antibiotic NeoC-1027 chromophore I

antibiotic NeoC-1027 chromophore I

C43H46ClN3O13 (847.2719016)


   

Aclarubicin hydrochloride

Aclarubicin hydrochloride

C42H54ClNO15 (847.3181804)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

   

Aclarubicin hydrochloride

Aclarubicin hydrochloride

C42H53NO15.HCl (847.3181804)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

   

Cyclo(RGDyK) (trifluoroacetate)

Cyclo(RGDyK) (trifluoroacetate)

C31H43F6N9O12 (847.2935229999999)


Cyclo(RGDyK) trifluoroacetate is a potent and selective αVβ3 integrin inhibitor with an IC50 of 20 nM.

   

n-[3-(acetyloxy)-1-{[12-(4,4-dichloropentyl)-16-isopropyl-13-methyl-2,10,14-trioxo-3,11,15-trioxa-7,18-dithia-20,21-diazatricyclo[15.2.1.1⁶,⁹]henicosa-1(19),6(21),8,17(20)-tetraen-5-yl]oxy}-6-methyl-1-oxoheptan-4-yl]butanimidic acid

n-[3-(acetyloxy)-1-{[12-(4,4-dichloropentyl)-16-isopropyl-13-methyl-2,10,14-trioxo-3,11,15-trioxa-7,18-dithia-20,21-diazatricyclo[15.2.1.1⁶,⁹]henicosa-1(19),6(21),8,17(20)-tetraen-5-yl]oxy}-6-methyl-1-oxoheptan-4-yl]butanimidic acid

C37H51Cl2N3O11S2 (847.2341916000001)


   

n-[(3r,4s)-3-(acetyloxy)-1-{[(5r,12s,13s,16s)-12-(4,4-dichloropentyl)-16-isopropyl-13-methyl-2,10,14-trioxo-3,11,15-trioxa-7,18-dithia-20,21-diazatricyclo[15.2.1.1⁶,⁹]henicosa-1(19),6(21),8,17(20)-tetraen-5-yl]oxy}-6-methyl-1-oxoheptan-4-yl]butanimidic acid

n-[(3r,4s)-3-(acetyloxy)-1-{[(5r,12s,13s,16s)-12-(4,4-dichloropentyl)-16-isopropyl-13-methyl-2,10,14-trioxo-3,11,15-trioxa-7,18-dithia-20,21-diazatricyclo[15.2.1.1⁶,⁹]henicosa-1(19),6(21),8,17(20)-tetraen-5-yl]oxy}-6-methyl-1-oxoheptan-4-yl]butanimidic acid

C37H51Cl2N3O11S2 (847.2341916000001)


   

19-amino-23-chloro-4-{[(2s,3r,4r,5s)-5-(dimethylamino)-3,4-dihydroxy-6,6-dimethyloxan-2-yl]oxy}-22-hydroxy-17-oxo-2,16-dioxapentacyclo[18.2.2.1⁹,¹³.0³,¹⁰.0⁴,⁸]pentacosa-1(22),5,7,9(25),10,12,20,23-octaen-14-yl 3-hydroxy-7-methoxy-2-methyl-2h-1,4-benzoxazine-5-carboxylate

19-amino-23-chloro-4-{[(2s,3r,4r,5s)-5-(dimethylamino)-3,4-dihydroxy-6,6-dimethyloxan-2-yl]oxy}-22-hydroxy-17-oxo-2,16-dioxapentacyclo[18.2.2.1⁹,¹³.0³,¹⁰.0⁴,⁸]pentacosa-1(22),5,7,9(25),10,12,20,23-octaen-14-yl 3-hydroxy-7-methoxy-2-methyl-2h-1,4-benzoxazine-5-carboxylate

C43H46ClN3O13 (847.2719016)